Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vipivotide tetraxetan Linker (PSMA-617 Linker) is a noncleavable peptide linker utilized in the synthesis of Vipivotide tetraxetan (PSMA-617), a ligand instrumental in producing 177Lu-PSMA-617. This radioactive molecule is applied in the treatment of prostate cancer[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Vipivotide tetraxetan Linker (PSMA-617 Linker) is a noncleavable peptide linker utilized in the synthesis of Vipivotide tetraxetan (PSMA-617), a ligand instrumental in producing 177Lu-PSMA-617. This radioactive molecule is applied in the treatment of prostate cancer[1]. |
Synonyms | PSMA-617 Linker |
Molecular Weight | 655.74 |
Formula | C33H45N5O9 |
CAS No. | 1703768-74-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 270 mg/mL (411.75 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vipivotide tetraxetan Linker 1703768-74-4 Others PSMA-617 Linker inhibitor inhibit